Inhibition of angiogenesis: thalidomide or low-molecular-weight heparin?
- PMID: 15774812
- DOI: 10.1200/JCO.2005.05.245
Inhibition of angiogenesis: thalidomide or low-molecular-weight heparin?
Comment on
-
Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer.J Clin Oncol. 2004 Jul 1;22(13):2532-9. doi: 10.1200/JCO.2004.05.074. J Clin Oncol. 2004. PMID: 15226321 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
